Search results for "TUMORS"

showing 10 items of 1138 documents

IL TERATOMA ED IL CHIRURGO PEDIATRA. Considerazioni sull'approccio e valutazioni dalla Casistica Nazionale "TCG 91".

1996

Germ Cell Tumors (GCT) are rare in childhood, accounting for 2-4% of all solid neoplasms. Teratoma is the most frequent histological type (50%) of GCT and the most important neonatal tumors.. Authors analyze the results of the first Italian Multicentric Cooperative Study on GCTs in childhood (TCG 91). The role of surgical radical excision of the mass with thw coccyx in sacrococcygeal forms is streassed.

Pediatric neoplasms Germ Cell Tumors Teratomas.Settore MED/38 - Pediatria Generale E SpecialisticaSettore MED/20 - Chirurgia Pediatrica E Infantile
researchProduct

GERM CELL TUMORS OF THE TESTIS (tgct) IN CHOLDHOOD. A Review from a National Case Report

1994

Tha Authors report a retrospective Study carried out because of the rarity of Primary Testicular Tumors (PTT) in childhood. The aim was to revise the surgical treatment performed in 60 Pz affected by PTT during a 10 year period.

Pediatric tumors. Germ Cel Tumors Testicular Tumors National report.Settore MED/38 - Pediatria Generale E SpecialisticaSettore MED/20 - Chirurgia Pediatrica E Infantile
researchProduct

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcino…

2020

Background: Systemic chemotherapy for pancreatic adenocarcinoma (PDAC) and cholangiocarcinoma (CC) with peritoneal metastases (PM) is affected by several pharmacological shortcomings and low clinical efficacy. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is expected to maximize exposure of peritoneal nodules to antiblastic agents. This study aims to evaluate safety and efficacy of PIPAC for PM of PDAC and CC origin. Methods: This is a retrospective analysis of consecutive PDAC and CC cases with PM treated with PIPAC at two European referral centers for peritoneal disease. We prospectively recorded from August 2016 to May 2019 demographic, clinical, surgical, and oncological data…

Peritoneal metastasismedicine.medical_treatmentSettore MED/18 - CHIRURGIA GENERALEpancreatic cancerPIPACcarcinomatosislcsh:RC254-282Pancreatic cancerMedicineDoxorubicincarcinomatosiOriginal ResearchCisplatinChemotherapybusiness.industrySystemic chemotherapyperitoneal metastaseaerosol chemotherapymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensdigestive system diseasesOxaliplatinperitoneal metastasesOncologyCancer researchlocoregional chemotherapyAdenocarcinomaPIPAC.businesscholangiocarcinomamedicine.drugTherapeutic Advances in Medical Oncology
researchProduct

Gold(I) compounds with lansoprazole-type ligands

2014

A number of gold(I) complexes containing the proton pump inhibitor (PPI) lansoprazole and its reduced precursor 2-((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methylthio)-1H-benzo[d]imidazole have been synthesized and their biological effects have been evaluated in human cancer and nontumorigenic cells in vitro. The lansoprazole-based compounds appear to act through a V-H+-ATPase-mediated mechanism.

PharmacologyStereochemistryOrganic ChemistryLansoprazolePharmaceutical ScienceANTIPROLIFERATIVE PROPERTIESSERIESBiochemistryTUMORSIn vitroPROTON-PUMP INHIBITORSchemistry.chemical_compoundchemistryCHEMISTRYTARGETSDrug DiscoverymedicineMolecular MedicineImidazoleSOLUTION BEHAVIORCOMPLEXESAGENTSHuman cancerRESISTANCEmedicine.drugMedChemCommun
researchProduct

Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study

2021

Background Despite its proven activity as third-line treatment in gastrointestinal stromal tumors (GIST), regorafenib can present a poor tolerability profile which often leads to treatment modifications and transient or permanent discontinuation; thus, in clinical practice physicians usually adopt various dosing and interval schedules to counteract regorafenib-related adverse events and avoid treatment interruption. The aim of this real-world study was to investigate the efficacy and safety of personalized schedules of regorafenib in patients with metastatic GIST, in comparison with the standard schedule (160 mg daily, 3-weeks-on, 1-week-off). Patients and methods Institutional registries a…

Phenylurea CompoundOncologyCancer Researchmedicine.medical_specialtyScheduleStromal cellPyridinesGastrointestinal Stromal TumorsPyridinePersonalized treatmentchemical and pharmacologic phenomenaMultikinase inhibitorchemistry.chemical_compoundQuality of lifeRetrospective Studieimmune system diseaseshemic and lymphatic diseasesInternal medicineRegorafenibmedicineHumansOriginal ResearchRetrospective StudiesGiSTbusiness.industryPhenylurea Compoundstoxicityhemic and immune systemspersonalized treatmentdigestive system diseasesquality of lifeOncologychemistryregorafenibGIST; personalized treatment; quality of life; regorafenib; toxicity; Humans; Phenylurea Compounds; Pyridines; Retrospective Studies; Gastrointestinal Stromal TumorsbusinessHumanGISTESMO Open
researchProduct

Piezosurgery in the excision of middle ear tumors: effects on mineralized and non mineralized tissues

2007

BACKGROUND: Piezosurgery is a new instrument able to cut bone without necrosis and non-mineralized tissue damage. The aim of this study was to test the Piezosurgery as a new and alternative method for the excision of middle-ear tumors and to analyze its effects on soft tissues. MATERIAL/METHODS: The Piezosurgery device was used to excise eight glomus tympanicum tumors and two primary B-cell lymphomas of the middle ear. The piezoelectric device uses low-frequency ultrasonic waves (24.7-29.5 kHz); the applied power can be modulated between 2.8 and 16 W and is programmed in accordance to the density of the bone. The equipment consists of two hand-pieces, two inserts, and two peristaltic pumps.…

Piezosurgery middle ear tumors
researchProduct

Inflammatory pituitary lesions

2021

Abstract Inflammatory pituitary lesions are rare but important differential diagnoses of nonfunctioning pituitary masses. Primary hypophysitis as an autoimmune disorder has received increasing attention over the past decades. In the last decade, immune checkpoint inhibitor–induced hypophysitis has emerged as a new type of secondary hypophysitis. Various pituitary tumors may also cause secondary hypophysitis. Systemic, noninfectious granulomatous diseases that can involve the pituitary region include sarcoidosis, granulomatosis with polyangiitis, Langerhans cell histiocytosis, Erdheim-Chester disease, and Rosai-Dorfman disease. Furthermore, infectious diseases can affect the pituitary gland.…

Pituitary glandPathologymedicine.medical_specialtybusiness.industryHypophysitisPituitary tumorsDiseasemedicine.diseasemedicine.anatomical_structureLangerhans cell histiocytosismedicineSarcoidosisDifferential diagnosisbusinessGranulomatosis with polyangiitis
researchProduct

Polymorphous low grade adenocarcinoma : review and case report

2007

Polymorphous Low-Grade Adenocarcinoma is a rare, malignant salivary gland tumor, which is found almost exclusively in minor salivary glands. It is more frequent in the age range from 30 to 70, with a clear female predilection in a 2:1 ratio. It is usually located in the hard or soft palate, although it may be found in the rest of the oral cavity too. It is rare in major salivary glands. In general it has good prognosis, with recurrence rates in the range of 17% - 24%. Although rare, metastasis to regional lymph nodes may occur in 9% of the cases. This report describes the case of a patient that consulted at the Military Odontological Center (Central Odontológica del Ejército) due to an esth…

Polymorphous low grade adenocarcinomaUNESCO::CIENCIAS MÉDICASsalivary gland tumors:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts

2016

Background: Keratin-producing odontogenic cysts (KPOCs) are a group of cystic lesions that are often aggressive, with high rates of recurrence and multifocality. KPOCs included orthokeratinised odontogenic cyst (OOC) and parakeratotic odontogenic cysts, which are now considered true tumours denominated keratocystic odontogenic tumours (KCOTs). GLUT1 is a protein transporter that is involved in the active uptake of glucose across cell membranes and that is overexpressed in tumours in close correlation with the proliferation rate and positron emission tomography (PET) imaging results. Methods: A series of 58 keratin-producing odontogenic cysts was evaluated histologically and immunohistochemi…

Positron emission tomographyPathologymedicine.medical_specialtyKeratocystic odontogenic tumourOdontogenic TumorsOdontologia03 medical and health sciences0302 clinical medicineKeratocystic odontogenic tumourGlucose transporter proteinKeratinmedicineHumansCàncerGeneral Dentistrychemistry.chemical_classificationGlucose Transporter Type 1medicine.diagnostic_testbiologyDentistry(all)business.industryKeratin-producing odontogenic cystGlucose transporterCancerEpithelial Cells030206 dentistrymedicine.diseasePatologiaImmunohistochemistryOrthokeratinised odontogenic cystchemistryPositron emission tomography030220 oncology & carcinogenesisOdontogenic Cystsbiology.proteinKeratinsImmunohistochemistryGLUT1businessGlucose Transporter Type 1Research ArticleBMC Oral Health
researchProduct

Editorial debate: Challenges we oncologists, working within a universal healthcare system, have to face in these hard times

2020

I have been very much impressed by the clarity, pragmatism and good medical judgement of the article by Camilo Porta,1 a respected and dedicated ESMO faculty member and friend, giving his personal perspective on real issues many oncologists working in a public system are eventually facing during the SARS-CoV-2 pandemic. I understand Professor Porta is voicing what many oncologists from countries deeply affected by the pandemic, such as Italy or Spain, may think. Although I concur with most of his approaches and comments, I would like to complement some of these statements with some additional thoughts. Medicine was created more than 2500 years ago as a profession aiming at alleviating suffe…

PragmatismCancer Researchbusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectPerspective (graphical)JudgementFace (sociological concept)Public relationslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282law.inventionOncologylawPolitical sciencePandemicCLARITYbusinessmedia_commonHealthcare systemESMO Open
researchProduct